Stocks continued to be under pressure as investors navigated the uncertainty surrounding tariffs and growing concerns about a recession. The S&P 500 officially moved into correction territory, marked ...

As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top ...

The new exhibition honors the healthcare workers, community members and public officials that worked to build trust in the medical community during a time of crisis and uncertainty.

Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with ...

Misinformation about vaccines has swirled online since US President Donald Trump appointed Robert F. Kennedy Jr. – who has ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

The cutting-edge technology used in COVID-19 shots may lead to new treatments for other diseases. But some conservatives are ...

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

Vaccine hesitancy and higher rates of school vaccine exemptions increases the risk of outbreaks of preventable diseases, creating a significant health risk for vulnerable populations.

NPR reports on the National Institutes of Health funding cuts with insight from two NIH staffers and one person familiar with NIH's activities who requested anonymity because they were not authorized ...

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...

BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 ...